Huq Aamira, Nand Kushma, Juneja Rajiv, Winship Ingrid
Department of Genomic Medicine, The Royal Melbourne Hospital, Parkville, Victoria, Australia.
Department of Nephrology, Western Health, Footscray, Australia.
BMJ Case Rep. 2018 Oct 23;2018:bcr-2018-225742. doi: 10.1136/bcr-2018-225742.
Adenine phosphoribosyltransferase (APRT) deficiency is a rare autosomal recessive disorder which leads to accumulation of poorly soluble 2,8-dihydroxyadenine in kidneys resulting in nephrolithiasis as well as chronic kidney disease from crystal nephropathy. This report describes a 55-year-old previously fit man who presented with shortness of breath and the investigative pathway that eventually led to a diagnosis of APRT deficiency. Early diagnosis has aided in timely institution of allopurinol, thereby improving his renal function and possibility of weaning off renal replacement therapy. Genetic testing has enabled early identification of other family members at risk and prevention of renal failure by commencing xanthine oxidoreductase (XOR) inhibitors. The issues surrounding kidney donation by a member of this family are also discussed. This case represents the importance of awareness and recognition of the signs and symptoms of this rare condition, complications of which can be easily prevented by early institution of XOR inhibitor therapy.
腺嘌呤磷酸核糖转移酶(APRT)缺乏症是一种罕见的常染色体隐性疾病,可导致难溶性2,8 - 二羟基腺嘌呤在肾脏中积聚,从而引发肾结石以及由晶体肾病导致的慢性肾病。本报告描述了一名55岁、既往健康的男性,他因呼吸急促就诊,其检查过程最终确诊为APRT缺乏症。早期诊断有助于及时使用别嘌醇,从而改善其肾功能,并有可能停用肾脏替代治疗。基因检测能够早期识别其他有风险的家庭成员,并通过开始使用黄嘌呤氧化还原酶(XOR)抑制剂预防肾衰竭。本文还讨论了该家族一名成员进行肾脏捐献的相关问题。该病例体现了认识和识别这种罕见疾病的体征和症状的重要性,通过早期使用XOR抑制剂治疗,其并发症很容易得到预防。